Back to search
Chemotherapy-Induced Myelosuppression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chemotherapy-Induced Myelosuppression trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Chemotherapy-Induced Myelosuppression trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a multicenter, randomized, double-blind, placebo-controlled study to assess whether trilaciclib administered prior to topotecan is non-inferior to place…
The purpose of the study is to explore the safety and efficacy of UCMSC-Exo in consolidation chemotherapy-induced myelosuppression in patients with acute myeloi…
The goal of this clinical trial is to learn if Naderin works to prevent low white blood cell counts in people with breast cancer receiving first-line chemothera…
This is a Phase 2, multicenter, randomized, open-label study evaluating the safety and efficacy of trilaciclib administered with platinum-based chemotherapy fol…